Peng Gu

922 total citations
28 papers, 432 citations indexed

About

Peng Gu is a scholar working on Molecular Biology, Surgery and Epidemiology. According to data from OpenAlex, Peng Gu has authored 28 papers receiving a total of 432 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 6 papers in Surgery and 5 papers in Epidemiology. Recurrent topics in Peng Gu's work include RNA modifications and cancer (5 papers), Cancer-related molecular mechanisms research (4 papers) and Gut microbiota and health (3 papers). Peng Gu is often cited by papers focused on RNA modifications and cancer (5 papers), Cancer-related molecular mechanisms research (4 papers) and Gut microbiota and health (3 papers). Peng Gu collaborates with scholars based in China, United States and Sweden. Peng Gu's co-authors include Xu Chen, Jian Huang, Tianxin Lin, Weibin Xie, Guangzheng Zhong, Ruihui Xie, Wang He, Jinli Han, Wen Dong and Qingqing Cai and has published in prestigious journals such as Journal of Clinical Investigation, Scientific Reports and Journal of Hepatology.

In The Last Decade

Peng Gu

26 papers receiving 430 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peng Gu China 11 334 136 55 40 39 28 432
Dan‐Ming Wei China 11 271 0.8× 182 1.3× 34 0.6× 74 1.9× 59 1.5× 26 422
Youguang Huang China 10 230 0.7× 132 1.0× 38 0.7× 86 2.1× 38 1.0× 20 353
Yunfei Duan China 12 198 0.6× 149 1.1× 54 1.0× 53 1.3× 49 1.3× 17 350
Yiping Dong China 13 239 0.7× 131 1.0× 35 0.6× 59 1.5× 91 2.3× 30 403
Lei Lü China 12 247 0.7× 227 1.7× 59 1.1× 42 1.1× 54 1.4× 15 406
Deven Patel United States 8 228 0.7× 142 1.0× 42 0.8× 24 0.6× 62 1.6× 8 352
Jun Ouyang China 13 330 1.0× 159 1.2× 64 1.2× 37 0.9× 53 1.4× 29 505
Feng Cao China 13 200 0.6× 151 1.1× 82 1.5× 75 1.9× 62 1.6× 33 385
Longci Sun China 9 197 0.6× 127 0.9× 29 0.5× 71 1.8× 53 1.4× 17 327
Wang Li China 11 218 0.7× 119 0.9× 25 0.5× 60 1.5× 50 1.3× 37 348

Countries citing papers authored by Peng Gu

Since Specialization
Citations

This map shows the geographic impact of Peng Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peng Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peng Gu more than expected).

Fields of papers citing papers by Peng Gu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peng Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peng Gu. The network helps show where Peng Gu may publish in the future.

Co-authorship network of co-authors of Peng Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Peng Gu. A scholar is included among the top collaborators of Peng Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peng Gu. Peng Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Jiaxin, Mei‐Ling Chen, Yuqi Chen, et al.. (2025). Panose prevents acute-on-chronic liver failure by reducing bacterial infection in mice. Journal of Clinical Investigation. 135(14).
3.
Yang, Qin, Li Xie, Tao Chen, et al.. (2024). Oral administration of astilbin mitigates acetaminophen-induced acute liver injury in mice by modulating the gut microbiota. Acta Pharmacologica Sinica. 46(2). 416–429. 1 indexed citations
4.
Li, Dongping, Zhelin Zhang, Yi‐Feng Qiu, et al.. (2024). Zinc promotes microbial p-coumaric acid production that protects against cholestatic liver injury. Cell Host & Microbe. 32(12). 2195–2211.e9. 7 indexed citations
5.
Cai, Shijiao, Yanyan Chen, Jing Zhang, et al.. (2024). Atorvastatin improved ulcerative colitis in association with gut microbiota-derived tryptophan metabolism. Life Sciences. 351. 122790–122790. 10 indexed citations
6.
Gu, Peng, Jiaxin Li, Zhenhua Zeng, et al.. (2023). A metabolite from commensal Candida albicans enhances the bactericidal activity of macrophages and protects against sepsis. Cellular and Molecular Immunology. 20(10). 1156–1170. 12 indexed citations
7.
Gu, Peng, et al.. (2022). Hsa_circ_0019054 up-regulates HIF1A through sequestering miR-340–5p to promote the tumorigenesis of intrahepatic cholangiocarcinoma. Human & Experimental Toxicology. 41. 3520144734–3520144734. 6 indexed citations
8.
Zhou, Hao, et al.. (2021). Endothelial glycocalyx degradation is associated with early organ impairment in polytrauma patients. BMC Emergency Medicine. 21(1). 52–52. 11 indexed citations
9.
Gu, Peng, Qin Yang, Wen Liu, et al.. (2021). Genetically blocking HPD via CRISPR-Cas9 protects against lethal liver injury in a pig model of tyrosinemia type I. Molecular Therapy — Methods & Clinical Development. 21. 530–547. 11 indexed citations
10.
Wang, Ruibin, et al.. (2021). CircRTN4IP1 regulates the malignant progression of intrahepatic cholangiocarcinoma by sponging miR-541-5p to induce HIF1A production. Pathology - Research and Practice. 230. 153732–153732. 16 indexed citations
12.
Gu, Peng, Yuting Chen, Xiaoxu Zhou, et al.. (2019). TZAP plays an inhibitory role in the self-renewal of porcine mesenchymal stromal cells and is implicated the regulation of premature senescence via the p53 pathway. Journal of Translational Medicine. 17(1). 72–72. 7 indexed citations
13.
Xie, Ruihui, Xu Chen, Ziyue Chen, et al.. (2019). Polypyrimidine tract binding protein 1 promotes lymphatic metastasis and proliferation of bladder cancer via alternative splicing of MEIS2 and PKM. Cancer Letters. 449. 31–44. 76 indexed citations
14.
Gu, Peng, Jun-Shuang Jia, Wei Liu, et al.. (2019). Optimization Strategy for Generating Gene-edited Tibet Minipigs by Synchronized Oestrus and Cytoplasmic Microinjection. International Journal of Biological Sciences. 15(12). 2719–2732. 5 indexed citations
15.
Liu, Yumin, Wei Liu, Jun-Shuang Jia, et al.. (2018). Abnormalities of hair structure and skin histology derived from CRISPR/Cas9-based knockout of phospholipase C-delta 1 in mice. Journal of Translational Medicine. 16(1). 141–141. 9 indexed citations
16.
Huang, Wukui, et al.. (2017). Metronomic S-1 chemotherapy plus transcatheter arterial chemoembolization (TACE): a promising treatment of hepatocellular carcinoma refractory to TACE.. PubMed. 21(4). 909–916. 5 indexed citations
17.
Liu, Mo, et al.. (2016). C6 ceramide sensitizes the anti-hepatocellular carcinoma (HCC) activity by AZD-8055, a novel mTORC1/2 dual inhibitor. Tumor Biology. 37(8). 11039–11048. 20 indexed citations
18.
Huang, Wukui, et al.. (2015). Jinlong capsule decreases adverse reactions after transcatheter arterial chemoembolization (TACE) in patients with hepatocellular carcinoma ⁎. Oncology and Translational Medicine. 1(2). 87–91. 3 indexed citations
19.
Chen, Xu, Peng Gu, Kuiqing Li, et al.. (2015). Gene expression profiling of WDR5 regulated genes in bladder cancer. Genomics Data. 5. 27–29. 16 indexed citations
20.
Chen, Xu, Weibin Xie, Peng Gu, et al.. (2015). Upregulated WDR5 promotes proliferation, self-renewal and chemoresistance in bladder cancer via mediating H3K4 trimethylation. Scientific Reports. 5(1). 8293–8293. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026